1. Home
  2. PRA vs COLL Comparison

PRA vs COLL Comparison

Compare PRA & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProAssurance Corporation

PRA

ProAssurance Corporation

HOLD

Current Price

$24.32

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$32.75

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRA
COLL
Founded
1976
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
PRA
COLL
Price
$24.32
$32.75
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$25.00
$51.40
AVG Volume (30 Days)
705.7K
500.6K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.99
1.73
Revenue
$1,098,028,000.00
$780,567,000.00
Revenue This Year
N/A
$8.01
Revenue Next Year
N/A
N/A
P/E Ratio
$24.43
$18.84
Revenue Growth
N/A
23.62
52 Week Low
$22.72
$23.23
52 Week High
$24.85
$50.79

Technical Indicators

Market Signals
Indicator
PRA
COLL
Relative Strength Index (RSI) 40.86 32.91
Support Level $24.17 $31.01
Resistance Level $24.41 $32.92
Average True Range (ATR) 0.17 1.24
MACD -0.04 0.23
Stochastic Oscillator 29.05 23.67

Price Performance

Historical Comparison
PRA
COLL

About PRA ProAssurance Corporation

ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: